Munehisa Fukushima

Munehisa Fukushima

Auto-generated profile, based on publicly available information

Munehisa Fukushima

Department of Otolaryngology and Head and Neck Surgery, Kansai Rosai Hospital, Amagasaki, Japan

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 December 2018 in The Laryngoscope
Verified
Journal Article
Closed access
PDF file
MFMunehisa Fukushima
Munehisa Fukushima
RORyohei Oya
Ryohei Oya
KNKengo Nozaki
Kengo Nozaki
HEHirotaka Eguchi
Hirotaka Eguchi
SAShiro Akahani
Shiro Akahani
NTNoriaki Takeda
Noriaki Takeda

31 October 2017 in Laryngoscope Investigative Otolaryngology
Verified
Journal Article
Open access
PDF file
MFMunehisa Fukushima
Munehisa Fukushima
TKTadashi Kitahara
Tadashi Kitahara
RORyohei Oya
Ryohei Oya
SAShiro Akahani
Shiro Akahani
HIHidenori Inohara
Hidenori Inohara
NTNoriaki Takeda
Noriaki Takeda
Objective/Hypothesis: Meniere's disease (MD) is a common inner ear disease characterized by repeated episodic vertigo, fluctuating sensorineural hearing loss, and tinnitus. Its pathology is defined as endolymphatic hydrops (EH) in the inner ear and EH has been hypothesized to correlate with the clinical symptoms of MD. We presented the dynamics of in vivo EH in MD patients during medical treatments.Study Design: Prospective, single‐arm repeated measuresMethods: Eleven MD patients were enrolled. All subjects prospectively underwent gadolinium‐enhanced inner ear magnetic resonance (MR) imaging and neuro‐otological testing before and after medical treatment. The volume of EH was quantitatively evaluated by processing MR images. All MD patients were administered continuous medication and followed up for more than 12 months.Results: The frequency of vertigo episodes decreased in all patients and vestibular function decreased to 13–91% of the pre‐treatment level. The volume ratio of post‐treatment EH‐to‐pre‐treatment EH ranged from 1.01–3.22. The total volume of pre‐treatment EH was significantly correlated with cochlear symptom disease duration and the affected ear's hearing level.Conclusion: EH in MD patients developed longitudinally with deterioration of inner ear function during medical treatment. The natural course of MD may progress with development of EH at least for a certain period.Level of Evidence: 2b.

1 April 2013 in Auris Nasus Larynx
Verified
Journal Article
Closed access
TMTakahiro Michiba
Takahiro Michiba
TKTadashi Kitahara
Tadashi Kitahara
NHNoriko Hikita-Watanabe
Noriko Hikita-Watanabe
MFMunehisa Fukushima
Munehisa Fukushima
YOYoshiyuki Ozono
Yoshiyuki Ozono
HIHidenori Inohara
Hidenori Inohara

1 September 2020 in JAMA Otolaryngology–Head & Neck Surgery
Verified
Journal Article
Open access
PDF file
MFMunehisa Fukushima
Munehisa Fukushima
YUYuya Ueno
Yuya Ueno
IKItsuki Kitayama
Itsuki Kitayama
SAShiro Akahani
Shiro Akahani
HIHidenori Inohara
Hidenori Inohara
NTNoriaki Takeda
Noriaki Takeda
Ménière disease is a common inner ear disease that is characterized by episodic vertigo, fluctuating sensorineural hearing loss, and tinnitus. The chronic course of Ménière disease has been explored in several studies and was summarized in a review.1 This research reported that vertiginous episodes improved, but both vestibular and hearing function deteriorated. In previous studies, vestibular function in patients with Ménière disease was typically evaluated using caloric testing, which assesses the function of the horizontal semicircular canal. However, the function of the vertical semicircular canals has not been extensively examined in patients with Ménière disease. Recently, the findings of vertical semicircular canal examinations using the video head impulse test (vHIT) have been reported to have a diagnostic association with Ménière disease, especially in the posterior semicircular canals of patients with Ménière disease.2

1 June 2019 in JAMA Otolaryngology–Head & Neck Surgery
Verified
Journal Article
Closed access
MFMunehisa Fukushima
Munehisa Fukushima
SAShiro Akahani
Shiro Akahani
HIHidenori Inohara
Hidenori Inohara
NTNoriaki Takeda
Noriaki Takeda

6 July 2016 in Acta Oto-Laryngologica
Verified
Journal Article
Closed access
MFMunehisa Fukushima
Munehisa Fukushima
RIRie Ito
Rie Ito
SMSinichi Miyaguchi
Sinichi Miyaguchi
THTakashi Hirai
Takashi Hirai
YOYusuke Otami
Yusuke Otami
NTNoriaki Takeda
Noriaki Takeda
Conclusion: Profound deafness (PD) is unlikely to be the only cause of endolymphatic hydrops (EH) in patients with delayed endolymphatic hydrops (DEH). Further studies in large patient cohorts are required to determine the etiologic co-factors involved in the development of EH in patients with PD and DEH. Objectives: DEH usually occurs in patients with sustained unilateral PD who then develop episodic vertigo or fluctuating hearing loss. The latency can vary markedly between PD and development of DEH, but the factors affecting inner ear homeostasis and causing EH during this latency period remain unclear. The study aimed to assess the differences in EH and functional status of the inner ear between patients with PD only and those with DEH. Method: Two PD and 10 DEH patients who had developed PD in early childhood were enrolled. Gadolinium-enhanced magnetic resonance imaging of the inner ear was performed in all patients to assess the degree of EH in the vestibule and cochlea. Results: There was no evidence of EH in the affected ears of patients with PD alone. DEH patients, however, showed significant EH in either the cochlea or vestibule, suggesting that EH development and DEH onset were strongly correlated.